TP53 and neoplasm: Statistically significant differences were observed between tumor and normal samples grouped based on clinical data such as age, tumor stage, lymph node metastasis, smoking habits, histological subtypes, and TP53‐muation status (Figure 2C–H), but there were no differences in race or gender (Figure 2A and B).